FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
This article was originally published in The Tan Sheet
Executive Summary
Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
You may also be interested in...
Senators Ask Why GMP Compliance Eludes Dietary Supplement Firms
Democrats Durbin and Blumenthal raise concerns about the “pervasiveness of poor manufacturing standards” in the supplement industry and demand to know what trade groups will do to improve compliance with good manufacturing practices.
Senators Ask Why GMP Compliance Eludes Dietary Supplement Firms
Democrats Durbin and Blumenthal raise concerns about the “pervasiveness of poor manufacturing standards” in the supplement industry and demand to know what trade groups will do to improve compliance with good manufacturing practices.
Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.